GENISTEIN

RestrictedCAS 446-72-07 regulations across 7 markets

GENISTEIN is a cosmetic ingredient classified as Skin Conditioning. Also known as CAS 446-72-0. It is regulated in 7 markets including UAE, Bahrain, European Union.

Also Known As

CAS Number
446-72-0

Market Overview — 29 Markets

European Union1
United Kingdom
United States
California
Maryland
Washington
Canada
Brazil
South Korea
Japan
Taiwan
Australia
Singapore
Malaysia
Thailand
Indonesia
Vietnam
Philippines
UAE1
Saudi Arabia1
Qatar1
Oman1
Kuwait1
Bahrain1
Russia
Belarus
Kazakhstan
Armenia
Kyrgyzstan

Detailed Regulations

Europe1 regulation
European UnionRestrictedAnnex III #373
Chemical name
Genisteol; 4',5,7-Trihydroxyisoflavone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone
CAS
446-72-0
Max concentration
0,007 %
Other conditions
From 1 February 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.

Source: EC 1223/2009 Annex III

AmericasNo restrictions

No specific restrictions for GENISTEIN in United States, California, Maryland, Washington, Canada, Brazil.

East Asia & OceaniaNo restrictions

No specific restrictions for GENISTEIN in South Korea, Japan, Taiwan, Australia.

ASEANNo restrictions

No specific restrictions for GENISTEIN in Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines.

GCC6 regulations
UAERestrictedAnnex III #373
Chemical name
Genisteol; 4',5,7-Trihydroxyisoflavone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone
CAS
446-72-0
Max concentration
0,007 %
Other conditions
From 1 February 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.

Source: GSO 1943:2024 (based on EU 1223/2009 III)

Saudi ArabiaRestrictedAnnex III #373
Chemical name
Genisteol; 4',5,7-Trihydroxyisoflavone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone
CAS
446-72-0
Max concentration
0,007 %
Other conditions
From 1 February 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.

Source: GSO 1943:2024 (based on EU 1223/2009 III)

QatarRestrictedAnnex III #373
Chemical name
Genisteol; 4',5,7-Trihydroxyisoflavone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone
CAS
446-72-0
Max concentration
0,007 %
Other conditions
From 1 February 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.

Source: GSO 1943:2024 (based on EU 1223/2009 III)

OmanRestrictedAnnex III #373
Chemical name
Genisteol; 4',5,7-Trihydroxyisoflavone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone
CAS
446-72-0
Max concentration
0,007 %
Other conditions
From 1 February 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.

Source: GSO 1943:2024 (based on EU 1223/2009 III)

KuwaitRestrictedAnnex III #373
Chemical name
Genisteol; 4',5,7-Trihydroxyisoflavone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone
CAS
446-72-0
Max concentration
0,007 %
Other conditions
From 1 February 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.

Source: GSO 1943:2024 (based on EU 1223/2009 III)

BahrainRestrictedAnnex III #373
Chemical name
Genisteol; 4',5,7-Trihydroxyisoflavone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone
CAS
446-72-0
Max concentration
0,007 %
Other conditions
From 1 February 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.

Source: GSO 1943:2024 (based on EU 1223/2009 III)

EAEUNo restrictions

No specific restrictions for GENISTEIN in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.

Frequently Asked Questions

Is GENISTEIN banned in any country?

GENISTEIN is not banned in any of the 26 markets tracked by Formpli. However, it may be subject to restrictions or conditions of use in some markets.

What are the restrictions on GENISTEIN in cosmetics?

GENISTEIN is restricted or has conditions of use in UAE, Bahrain, European Union, Kuwait, Oman, Qatar, Saudi Arabia. Restrictions may include maximum concentration limits, product type limitations, or mandatory labeling requirements. See the detailed regulations above for specifics.

Can I use GENISTEIN in cosmetics?

GENISTEIN is regulated in 7 markets. It has restrictions in UAE, Bahrain, European Union, Kuwait, Oman, Qatar, Saudi Arabia. Use Formpli's free screening tool to check your full ingredient list against all 26 markets at once.

Screen GENISTEIN with your full formula

Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.

Check Ingredients Free

This information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.